Skip to main content

Market Overview

NeuBase Therapeutics, Inc. (NBSE)

4.83 -0.08 (-1.63%)

Analyst Ratings

DateResearch FirmActionCurrentPT
2/12/21HC Wainwright & Co.MaintainsBuy18.0
6/16/20RBC CapitalInitiates Coverage OnOutperform16.0
4/01/20Chardan CapitalMaintainsBuy18.0
3/06/20Chardan CapitalInitiates Coverage OnBuy14.0
2/07/20Guggenheim SecuritiesInitiates Coverage OnBuy13.0
11/21/19OppenheimerInitiates Coverage OnOutperform14.0
10/29/19HC Wainwright & Co.Initiates Coverage OnBuy14.0
9/24/19BTIGInitiates Coverage OnBuy15.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter